Donald R. Skillman

990 total citations
17 papers, 796 citations indexed

About

Donald R. Skillman is a scholar working on Infectious Diseases, Virology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Donald R. Skillman has authored 17 papers receiving a total of 796 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Virology and 4 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Donald R. Skillman's work include HIV Research and Treatment (6 papers), Immune Cell Function and Interaction (3 papers) and HIV/AIDS Research and Interventions (3 papers). Donald R. Skillman is often cited by papers focused on HIV Research and Treatment (6 papers), Immune Cell Function and Interaction (3 papers) and HIV/AIDS Research and Interventions (3 papers). Donald R. Skillman collaborates with scholars based in United States, Netherlands and Thailand. Donald R. Skillman's co-authors include Monte S. Meltzer, Howard E. Gendelman, Debra Chester Kalter, Peter J. Gomatos, David L. Hoover, Jim A. Turpin, Lynn W. Kitchen, David W. Vaughn, K Wagner and Joseph L. Malone and has published in prestigious journals such as Annual Review of Immunology, Clinical Infectious Diseases and Journal of Medicinal Chemistry.

In The Last Decade

Donald R. Skillman

17 papers receiving 769 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Donald R. Skillman United States 14 392 268 230 202 136 17 796
E Balestra Italy 20 536 1.4× 476 1.8× 185 0.8× 270 1.3× 52 0.4× 47 1.1k
Mary J. Connell United States 15 333 0.8× 304 1.1× 217 0.9× 295 1.5× 111 0.8× 32 1.0k
Martin Delaney United States 5 583 1.5× 444 1.7× 263 1.1× 153 0.8× 59 0.4× 9 873
Darren Jardine Australia 10 238 0.6× 219 0.8× 78 0.3× 107 0.5× 34 0.3× 17 436
Laura Díaz Spain 16 499 1.3× 373 1.4× 146 0.6× 163 0.8× 45 0.3× 24 843
Kim Sannerud United States 10 641 1.6× 566 2.1× 130 0.6× 317 1.6× 32 0.2× 14 941
Gundula Notheis Germany 16 197 0.5× 475 1.8× 400 1.7× 217 1.1× 54 0.4× 39 1.1k
Mostafa Nokta United States 19 455 1.2× 414 1.5× 221 1.0× 439 2.2× 63 0.5× 48 1.1k
Meritxell Genescà Spain 19 475 1.2× 221 0.8× 456 2.0× 198 1.0× 48 0.4× 40 1.0k
C. Korin Bullen United States 12 918 2.3× 735 2.7× 421 1.8× 185 0.9× 93 0.7× 15 1.3k

Countries citing papers authored by Donald R. Skillman

Since Specialization
Citations

This map shows the geographic impact of Donald R. Skillman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald R. Skillman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald R. Skillman more than expected).

Fields of papers citing papers by Donald R. Skillman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald R. Skillman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald R. Skillman. The network helps show where Donald R. Skillman may publish in the future.

Co-authorship network of co-authors of Donald R. Skillman

This figure shows the co-authorship network connecting the top 25 collaborators of Donald R. Skillman. A scholar is included among the top collaborators of Donald R. Skillman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald R. Skillman. Donald R. Skillman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Kozar, Michael P., Kirsten S. Smith, Jason Sousa, et al.. (2007). Role of Specific Cytochrome P450 Isoforms in the Conversion of Phenoxypropoxybiguanide Analogs in Human Liver Microsomes to Potent Antimalarial Dihydrotriazines. Drug Metabolism and Disposition. 36(2). 380–385. 10 indexed citations
2.
Li, Qigui, Michael P. Kozar, Todd Shearer, et al.. (2007). Pharmacokinetics, Safety, and Hydrolysis of Oral Pyrroloquinazolinediamines Administered in Single and Multiple Doses in Rats. Antimicrobial Agents and Chemotherapy. 51(8). 2898–2904. 3 indexed citations
3.
Kitchen, Lynn W., David W. Vaughn, & Donald R. Skillman. (2006). Reviews Of Anti‐infective Agents: Role of US Military Research Programs in the Development of US Food and Drug Administration–Approved Antimalarial Drugs. Clinical Infectious Diseases. 43(1). 67–71. 39 indexed citations
4.
Hicks, Rickey P., et al.. (2005). The Medicinal Chemistry of Botulinum, Ricin and Anthrax Toxins. Current Medicinal Chemistry. 12(6). 667–690. 30 indexed citations
5.
Shearer, Todd, Michael P. Kozar, Michael T. O’Neil, et al.. (2005). In Vitro Metabolism of Phenoxypropoxybiguanide Analogues in Human Liver Microsomes to Potent Antimalarial Dihydrotriazines. Journal of Medicinal Chemistry. 48(8). 2805–2813. 19 indexed citations
6.
Guan, Jian, Quan Zhang, Montip Gettayacamin, et al.. (2004). Structure identification and prophylactic antimalarial efficacy of 2-guanidinoimidazolidinedione derivatives. Bioorganic & Medicinal Chemistry. 13(3). 699–704. 16 indexed citations
7.
Arness, Mark K, Brian H. Feighner, Stephan S. Monroe, et al.. (2000). Norwalk-Like Viral Gastroenteritis Outbreak in U.S. Army Trainees. Emerging infectious diseases. 6(2). 204–207. 40 indexed citations
8.
Schneider, H., Kenneth A. Schmidt, Donald R. Skillman, et al.. (1996). Sialylation Lessens the Infectivity of Neisseria gonorrhoeae MS11mkC. The Journal of Infectious Diseases. 173(6). 1422–1427. 36 indexed citations
9.
Skillman, Donald R., Joseph L. Malone, Catherine F. Decker, et al.. (1996). Phase I Trial of Interferon Alfa-n3 in Early-Stage Human Immunodeficiency Virus Type 1 Disease: Evidence for Drug Safety, Tolerance, and Antiviral Activity. The Journal of Infectious Diseases. 173(5). 1107–1114. 39 indexed citations
10.
Mapou, Robert L., Wendy Law, K Wagner, Joseph L. Malone, & Donald R. Skillman. (1996). Neuropsychological effects of Interferon Alfa-n3 treatment in asymptomatic human immunodeficiency virus-1-infected individuals. Journal of Neuropsychiatry. 8(1). 74–81. 22 indexed citations
11.
Sherwood, James A., G. Gachihi, R. Muigai, et al.. (1994). Phase 2 Efficacy Trial of an Oral 8-Aminoquinoline (WR6026) for Treatment of Visceral Leishmaniasis. Clinical Infectious Diseases. 19(6). 1034–1039. 72 indexed citations
12.
Skillman, Donald R., et al.. (1993). Increased Efficacy of Human Natural Interferon α (IFN-αn3) Versus Human Recombinant IFN-α2 for Inhibition of HIV-1 Replication in Primary Human Monocytes. AIDS Research and Human Retroviruses. 9(11). 1115–1122. 15 indexed citations
13.
Gendelman, Howard E., Donald R. Skillman, & Monte S. Meltzer. (1992). Interferon alpha (IFN)-Macrophage Interactions in Human Immunodeficiency Virus (HIV) Infection: Role of IFN in the Tempo and Progression of HIV Disease. International Reviews of Immunology. 8(1). 43–54. 15 indexed citations
14.
Meltzer, Monte S., Donald R. Skillman, Peter J. Gomatos, Debra Chester Kalter, & Howard E. Gendelman. (1990). Role of Mononuclear Phagocytes in the Pathogenesis of Human Immunodeficiency Virus Infection. Annual Review of Immunology. 8(1). 169–194. 240 indexed citations
15.
Meltzer, Monte S., Donald R. Skillman, David L. Hoover, et al.. (1990). Macrophages and the human immunodeficiency virus. Immunology Today. 11(6). 217–223. 140 indexed citations
16.
Gendelman, Howard E., et al.. (1990). Macrophage-HIV interaction. AIDS. 4(3). 221–228. 59 indexed citations
17.
Skillman, Donald R. & Charles W. Clark. (1987). HIV Infection and the Acquired Immunodeficiency Syndrome: A Strategy for Public Education. Military Medicine. 152(9). 479–480. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by E Balestra Breakdown of academic impact, for papers by Mary J. Connell Breakdown of academic impact, for papers by Martin Delaney Breakdown of academic impact, for papers by Darren Jardine Breakdown of academic impact, for papers by Laura Díaz Breakdown of academic impact, for papers by Kim Sannerud Breakdown of academic impact, for papers by Gundula Notheis Breakdown of academic impact, for papers by Mostafa Nokta Breakdown of academic impact, for papers by Meritxell Genescà Breakdown of academic impact, for papers by C. Korin Bullen
Rankless by CCL
2026